Benito P, Nelson GJ, Kelley DS, Bartolini G, Schmidt PC & Simon V (2001) The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 36, 229–236.
Blair SN, Haskell WL, Ho P, Paffenbarger RS Jr, Vranizan KM, Farquhar JW & Wood PD (1985) Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 122, 794–804.
Blankson H, Stakkestad JA, Fargertun H, Thom E, Wadstein J & Gudmundsen O (2000) Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 130, 2943–2948.
Eyjolfson V, Spriet LL & Dyck DJ (2004) Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc 36, 814–820.
Flint A, Raben A, Blundell JE & Astrup A (2000) Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 24, 38–48.
Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55, 628–634.
Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
Hawley JA & Noakes TD (1992) Peak sustained power output predicts VO2max and performance time in trained cyclists. Eur J Appl Physiol Occup Physiol 65, 79–83.
Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP & Belury MA (1998) Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 244, 678–682.
Kamphuis MM, Lejeune MP, Saris WH & Westerterp-Plantenga MS (2003 a) The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 27, 840–847.
Kamphius MMJW, Lejeune MPGM, Saris WHM & Westerterp-Plantenga MS (2003 b) The effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects. Eur J Clin Nutr 57, 1268–1274.
Matsuda M & DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycaemic insulin clamp. Diab Care 22, 1462–1470.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
Medina EA, Horn WF, Keim NL, Havel PJ, Benito P, Kelley D, Nelson GJ & Erickson KL (2000) Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite. Lipids 35, 783–788.
Moloney F, Yeow T, Mullen A, Nolan JJ & Roche HM (2004) Conjugated linoleic acid supplementation: insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 80, 887–895.
Noone EJ, Roche HM, Nugent AP & Gibney MJ (2002) The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 88, 243–251.
Perseghin G, Caumo A, Caloni M, Testolin G & Luzi L (2001) Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in non-obese individuals. J Clin Endocrinol Metab 86, 4776–4781.
Phillips DIW, Clark PM, Hales CN & Osmond C (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diab Med 11, 286–292.
Rahman SM, Wang Y, Yotsumoto H, Cha J, Han S, Inoue S & Yanagita T (2001) Effects of conjugated linoleic acid on serum leptin concentration, body-fat accumulation, and β-oxidation of fatty acid in OLEFT rats. Nutrition 17, 385–390.
Risérus U, Arner P, Brismar K & Vessby B (2002) Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabet Care 25, 1516–1521.
Risérus U, Berglund L & Vessby B (2001) Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord 25, 1129–1135.
Risérus U, Vessby B, Arnlov J & Basu S (2004 a) Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 80, 279–283.
Risérus U, Vessby B, Arner P & Zethelius B (2004 b) Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 47, 1016–1019.
Sartorio A, Lafortuna CL, Vangeli V, Tavani A, Bosetti C & La Vecchia C (2001) Short-term changes of cardiovascular risk factors after a non-pharmacological body weight reduction program. Eur J Clin Nutr 55, 865–869.
Stunkard AJ & Messick S (1985) The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 29, 71–83.
Terpstra AH (2001) Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate. J Nutr 131, 2067–2068.
Thom E, Wadstein J & Gudmundsen O (2001) Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 29, 392–396.
Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S & Matsuzawa Y (1999) Abdominal fat: standardized technique for measurement at CT. Radiology 211, 283–286.
Zambell KL, Keim NL, Van Loan MD, Gale B, Benito P, Kelley DS & Nelson GJ (2000) Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 35, 777–782.